nach oben

Critical Care

Erschienen in:

01.10.1999 | Review

Blood substitutes

verfasst von: DonatR Spahn

Erschienen in: Critical Care | Ausgabe 5/1999

Einloggen, um Zugang zu erhalten

Excerpt

Blood substitutes have long been sought after, and artificial oxygen carriers may soon become a reality. Despite increased safety of allogeneic blood in terms of transmission of infectious diseases [1], avoiding allogeneic blood transfusions remains an important goal in perioperative and intensive care medicine. This is because allogeneic blood transfusions may cause immunosuppression with an increased incidence of postoperative infections [2,3] and may adversely affect outcome in intensive care [4], and thus they remain a public concern [5]. …

Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP: Transfusion medicine. First of two parts - blood transfusion. N Engl J Med 1999, 340: 438-447. 10.1056/NEJM199902113400606CrossRefPubMed

Spahn DR, Leone BJ, Reves JG, Pasch T: Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 1994, 78: 1000-1021.CrossRefPubMed

Spahn DR, Schmid ER: Haemodilution in cardiac and vascular surgery. Curr Opin Anaesthesiol 1996, 9: 54-61.CrossRef

Hebert PC, Wells G, Blajchman MA, et al.: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999, 340: 409-417. 10.1056/NEJM199902113400601CrossRefPubMed

Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP: Transfusion medicine. Second of two parts - blood conservation. N Engl J Med 1999, 340: 525-533. 10.1056/NEJM199902183400706CrossRefPubMed

Keipert PE: Perfluorochemical emulsions: future alternatives to transfusion. Blood Subst Princ Meth Prod Clin Trials 1998, 2: 127-156.

Frietsch T, Lenz C, Waschke KF: Artificial oxygen carriers. Eur J Anaesth 1998, 15: 571-584. 10.1046/j.1365-2346.1998.00356.xCrossRef

Chang TM: Artificial cells with emphasis on cell encapsulation of genetically engineered cells. Artif Organs 1998, 22: 958-965. 10.1046/j.1525-1594.1998.06243.xCrossRefPubMed

Chang TM: Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin. Vox Sang 1998, 74 (suppl 2): 233-241.CrossRef

10.

Gould SA, Moss GS: Clinical development of human polymerized hemoglobin as a blood substitute. World J Surg 1996, 20: 1200-1207. 10.1007/s002689900183CrossRefPubMed

11.

Spahn DR, van Bremt R, Theilmeier G, et al.: Perflubron emulsion delays blood transfusion in orthopedic surgery. Anesthesiology 1999, in press.

12.

A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy : Practice guidelines for blood component therapy. Anesthesiology 1996, 84: 732-747.CrossRef

Titel: Blood substitutes
verfasst von: DonatR Spahn
Publikationsdatum: 01.10.1999
Verlag: BioMed Central
Erschienen in: Critical Care / Ausgabe 5/1999
Elektronische ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc363

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Blood substitutes

Excerpt

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/1999

Compliance characteristics of the Portex Soft Seal Cuff improves seal against leakage of fluid in a pig trachea model